SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-076462
Filing Date
2024-03-25
Accepted
2024-03-25 16:02:07
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B5 d773979d424b5.htm 424B5 506761
2 GRAPHIC g773979g00k01.jpg GRAPHIC 99185
3 GRAPHIC g773979g00k02.jpg GRAPHIC 137588
4 GRAPHIC g773979g00k03.jpg GRAPHIC 112242
5 GRAPHIC g773979g00k04.jpg GRAPHIC 222069
6 GRAPHIC g773979g00k05.jpg GRAPHIC 178079
7 GRAPHIC g773979g00k06.jpg GRAPHIC 185987
8 GRAPHIC g773979g00n13.jpg GRAPHIC 161605
9 GRAPHIC g773979g00n14.jpg GRAPHIC 177230
10 GRAPHIC g773979g01m01.jpg GRAPHIC 36798
11 GRAPHIC g773979g01m02.jpg GRAPHIC 116096
12 GRAPHIC g773979g01m03.jpg GRAPHIC 141550
13 GRAPHIC g773979g01m04.jpg GRAPHIC 143351
14 GRAPHIC g773979g01n14.jpg GRAPHIC 234590
15 GRAPHIC g773979g04a04.jpg GRAPHIC 49807
  Complete submission text file 0001193125-24-076462.txt   3184490
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255792 | Film No.: 24779150
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)